Several recent stories have caught the industry’s attention and set media imaginations alight, but none moreso than last week’s record-breaking US$3B marketing settlement between pharma giant GlaxoSmithKline and the US government. In short, GSK plead guilty to withholding safety data and illegal marketing practices related to three drugs and agreed to pay US$1B in criminal fines and US$2B to resolve civil complaints with the federal and several state governments. (more…)
“Basal cell carcinoma skin cancer is the most common form of skin cancer”. It’s a common claim and one which is undoubtedly true – non-melanoma skin cancers (or NMSCs) are seen far more frequently than any other form of cancer. Unfortunately, however, due to their frequency, statistics on the incidence of NMSCs (which include basal cell carcinomas, BCCs, and squamous cell carcinomas, SCCs, of the skin) are difficult to find and cross-reference.
Recognising this gap, a research group from the University of Nottingham established a literature review to try and establish what comparable published data could be found to determine the incidence of NMSCs. Whittling down some 3083 publications, the group identified 75 papers which provided suitable information, covering 38 countries from 1955-2007. (more…)
Earlier today we announced that two health insurers in Switzerland had agreed to reimburse SCENESSE® (afamelanotide) for the rare disease erythropoietic protoporphyria (EPP). While this is an encouraging step forward for the program and for Swiss patients, I felt it appropriate to take a moment to discuss the important role that Switzerland has played, and continues to play, in our EPP program.
In 2006 Clinuvel announced that it would commence a new clinical trial program focused on an unknown disease in a small open label study. At the time I noted that our aim was to “provide a prophylactic treatment for [a] debilitating and incurable skin disorder”. (more…)
There are a number of misconceptions about the interaction between sunlight and skin. In this two part post we look at what we think are the top five most common sun and skin myths.
Myth 1: I can’t get sunburnt on a cloudy day (more…)